Connor, Clark & Lunn Investment Management (CC&L)’s AdaptHealth AHCO Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45,819	Closed	-$456K	–	1534
2025 Q4	$456K	Sell	45,819 -318,024	-87%	-$3.04M	﹤0.01%	1321
2025 Q3	$3.26M	Sell	363,843 -280,489	-44%	-$2.6M	0.01%	704
2025 Q2	$6.08M	Buy	644,332 +242,347	+60%	+$2.14M	0.02%	523
2025 Q1	$4.36M	Buy	+401,985	New	+$4.04M	0.02%	533
2023 Q1	–	Sell	-211,593	Closed	-$4.07M	–	1224
2022 Q4	$4.07M	Buy	211,593 +37,503	+22%	+$793K	0.02%	390
2022 Q3	$3.27M	Buy	+174,090	New	+$3.58M	0.02%	401

Other funds holding AHCO

OCA

OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AHCO Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of AdaptHealth (AHCO) in Q1 2026, closing a stake of 45,819 shares — an estimated $456K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AHCO in Q3 2022 and held it in 6 quarters. The position peaked at $6.08M in Q2 2025. 242 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining AdaptHealth position as of Q1 2026 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 45,819 AdaptHealth shares in Q1 2026, an estimated $456K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AdaptHealth in Q3 2022 and held it in 6 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s AdaptHealth position peaked at $6.08M in Q2 2025.
242 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.